James Leonard Reus, MD Surgery - Vascular Surgery Medicare: Not Enrolled in Medicare Practice Location: 3610 Ensign Rd Ne, Olympia, WA 98506 Phone: 360-493-5252 Fax: 360-493-5257 |
Mrs. Kathleen Grace Turner, MD Surgery Medicare: Medicare Enrolled Practice Location: 3610 Ensign Rd Ne, Olympia, WA 98506 Phone: 360-493-5252 Fax: 360-493-5257 |
George M Brennan, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Road N.e., Group Health Olympia Medical Center, Olympia, WA 98506 Phone: 360-923-7530 |
Chris Nolan Griffith, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 3610 Ensign Rd Ne, Olympia, WA 98506 Phone: 360-493-5252 Fax: 360-493-5257 |
Louise May, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 128 Lilly Rd Ne Ste 205, Olympia, WA 98506 Phone: 360-493-7444 Fax: 360-236-7929 |
News Archive
Defibtech, LLC, a leading innovator in the Automated External Defibrillation (AED) market, today announced that it has received approval from Health Canada to market the Lifeline View™ AED device. The Lifeline View AED is the first and only AED to offer a full-color interactive display that shows users step-by-step how to perform CPR and external defibrillation.
Using fewer-;but higher-;doses of radiation to treat men with prostate cancer who had their prostates removed does not increase long-term side effects or lower their quality of life compared to conventional radiation treatment, a new, multi-institutional clinical trial shows.
The Gambia, Minister of Health Dr. Mariatou Jallow administered the first dose of the pneumococcal vaccine to Gambian children at a rural clinic outside Banjul today. Joined by the Gambia's Vice President, Mrs. Isatou Njie-Saidy, Dr. Jallow and hundreds of Gambian citizens celebrated this historic event, which marks the first step in the rollout of the Gambia's national pneumococcal immunisation programme.
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced the initiation of a dose escalation study with its oncology drug candidate tamibarotene combined with TRISENOX® (arsenic trioxide) injection (marketed by Cephalon, Inc.) in patients with relapsed acute promyelocytic leukemia (APL).
A new, first-of-its-kind research study was announced today that will analyze how changes in diet and lifestyle can impact long-term wellness and contribute to healthy aging.
› Verified 1 days ago